Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Todd C Davis

Director at Pelthos Therapeutics Inc. (PTHS)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-17.2%
vs. S&P 500-18.3%
Beat the market0%
Paper profit on buys−$263K
Total bought / sold$1000K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jun 15SEC PTHSPelthos Therapeutics Inc. Buy 35,44575,331 held (+89%) $27.80 $985K -26.3%
Jun 15SEC PTHSPelthos Therapeutics Inc. Buy 50375,834 held (+1%) $28.73 $14K -28.6%
  • Buy

    Director Todd C Davis bought $985K of PTHS at $27.80 — first open-market purchase in our records; raises the stake by 89%.